NCT07392801 AGE Accumulation in Patients on Long-term Parenteral Nutrition
| NCT ID | NCT07392801 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bordeaux |
| Condition | Chronic Intestinal Insufficiency |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-07-22 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-07-22 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective and observational study aims to evaluate the accumulation of advanced glycation end-products (AGEs) in adult and pediatric patients starting long-term parenteral nutrition, by non-invasive skin AGE measurements over a 12-month follow-up.
Eligibility Criteria
Inclusion Criteria: * Patients (adults and children, all ages) initiating long-term parenteral nutrition * Followed at CHU de Bordeaux or Robert Debré Hospital (APHP) * Covered by French Social Security system * Written informed consent obtained from patient (if adult) or legal guardian (if minor) Exclusion Criteria: * Fitzpatrick skin type ≥ V (darker skin tones) * Forearm tattoos at the site of measurement * For patients included under 1 year of age: patients born prematurely (before 37 weeks of amenorrhea) * Pregnant or breastfeeding women.
Contact & Investigator
Florian POULLENOT, MD
PRINCIPAL INVESTIGATOR
University Hospital, Bordeaux
Frequently Asked Questions
Who can join the NCT07392801 clinical trial?
This trial is open to participants of all sexes, studying Chronic Intestinal Insufficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07392801 currently recruiting?
Yes, NCT07392801 is actively recruiting participants. Contact the research team at florian.poullenot@chu-bordeaux.fr for enrollment information.
Where is the NCT07392801 trial being conducted?
This trial is being conducted at Bordeaux, France, Paris, France, Pessac, France.
Who is sponsoring the NCT07392801 clinical trial?
NCT07392801 is sponsored by University Hospital, Bordeaux. The principal investigator is Florian POULLENOT, MD at University Hospital, Bordeaux. The trial plans to enroll 50 participants.